Strados System at Center of Excellence
NCT04485741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2023-02-02
Summary
Listening to breath sounds with the stethoscope/auscultation is used by pulmonary physicians in conjunction with pulmonary function, signs and symptoms, oxygen saturation and diagnostic testing to admit, follow and discharge patients from hospital. Of these, only auscultation routinely ceases upon discharge from Hospital. Healthcare utilization statistics have shown that for more than a decade, readmission after discharge for an exacerbation of COPD or severe asthma (or chronic heart failure) remains a major problem. The Strados System has been designed to extend the range of lung sound recording both geographically and temporally to improve the standard of care when access to continuous monitoring has been replaced by periodic or no monitoring. The primary purpose of this study is to assess the clinical utility of the Strados System in enabling periodic recording and reviewing of breath sounds in patients with chronic respiratory diseases, either in the ICU, or in less continuously monitored settings, including after inpatient discharge.
Conditions
Interventions
- DEVICE
-
RESP
The RESP device will be placed on the patient for periodic recording of auscultory sound.
Sponsors & Collaborators
-
Strados Labs, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-23
- Primary Completion
- 2021-12-28
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients With COPD
NCT04671355 ·Status: WITHDRAWN ·Phase: PHASE4
-
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)
NCT05736874 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172300 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD
NCT06969573 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dynamic Hyperinflation and Tiotropium
NCT00569270 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02175342 ·Status: COMPLETED ·Phase: PHASE2
-
Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease
NCT02231359 ·Status: COMPLETED
-
Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients
NCT03795350 ·Status: TERMINATED ·Phase: PHASE1
-
COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
NCT04858451 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
NCT06533553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD
NCT06841640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia
NCT04527224 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects
NCT04231214 ·Status: COMPLETED ·Phase: PHASE4
-
Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)
NCT06663176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
NCT03265145 ·Status: COMPLETED ·Phase: PHASE4
-
Lung Health Study II
NCT00000569 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung
NCT01225965 ·Status: COMPLETED ·Phase: NA
-
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.
NCT01533935 ·Status: COMPLETED ·Phase: PHASE3
-
Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection
NCT01055847 ·Status: COMPLETED ·Phase: PHASE2
-
Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease.
NCT05495256 ·Status: COMPLETED ·Phase: NA
-
Treatment of Idiopathic Pulmonary Fibrosis with Long Acting Octreotide
NCT00463983 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
NCT04708782 ·Status: COMPLETED ·Phase: PHASE3
-
Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
NCT04780984 ·Status: COMPLETED ·Phase: PHASE2
-
Nasal Muco-ciliary Clearance Study With and Without Salt Inhalation
NCT04189016 ·Status: UNKNOWN ·Phase: NA
-
Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients
NCT01533922 ·Status: COMPLETED ·Phase: PHASE3